Skip to main content

JPMORGAN CHASE & CO

Position in RGNX — REGENXBIO Inc.

CIK 19617 NEW YORK, NY

Position in RGNX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$29,194,242
-$21,976,184 QoQ
Shares Held
3,483,800
-2.0% QoQ
Ownership
6.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 92.09633159193984.ToString("F0")% Shared 0.ToString("F0")% None 7.903668408060165.ToString("F0")%

Common Shares in RGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. RGNX ranks #45 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGNX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,194,242 3,483,800
2025-12-31 $51,170,426 3,553,502
2025-09-30 $38,959,441 4,037,248
2025-06-30 $31,625,123 3,852,025
2025-03-31 $31,205,050 4,364,343
2024-12-31 $31,975,274 4,136,517
2024-09-30 $25,986,988 2,477,311
2024-06-30 $35,245,967 3,012,476
2024-03-31 $78,434,189 3,722,553
2023-12-31 $70,714,902 3,939,549
2023-09-30 $60,331,890 3,665,364
2023-06-30 $73,994,562 3,701,579
2023-03-31 $75,746,330 4,005,623
2022-12-31 $86,058,737 3,794,477
2022-09-30 $107,164,529 4,054,655
2022-06-30 $104,848,930 4,244,896
2022-03-31 $156,812,559 4,724,693
2021-12-31 $163,656,075 5,004,773
2021-09-30 $173,562,464 4,140,326
2021-06-30 $144,593,676 3,721,845
2021-03-31 $119,414,980 3,500,879
2020-12-31 $117,997,960 2,601,366
2020-09-30 $54,657,800 1,986,112
2020-06-30 $70,550,109 1,915,561
2020-03-31 $48,678,341 1,503,346